Brought to you by:
Boston Scientific announces agreement to acquire Silk Road Medical
Boston Scientific has announced that it has entered into a definitive agreement to acquire Silk Road Medical, a medical device company involved in producing products to be deployed during transcarotid artery revascularisation (TCAR). The purchase price is US$27.50 per share,…
Verified vascular! Quality care in vascular disease
The Society for Vascular Surgery (SVS) and American College of Surgeons (ACS) Vascular Verification Program (Vascular-VP) will be a central focus on the opening day of the 2024 Vascular Annual Meeting (VAM) as the topic of the E. Stanley Crawford…
CEA vs TCAR: Surgeons should be familiar with both procedures and ‘collaborate as needed’
When it comes to the ongoing debate of carotid endarterectomy (CEA) versus transcarotid artery revascularization (TCAR) in the treatment of carotid artery stenosis, operators should be comfortable and maintain experience with both of these procedures—and “collaborate as needed.” That is…
VAM 2024: Enhancing clinical practice and patient interaction in CLTI
A key event on informed decision-making in chronic limb-threatening ischemia (CLTI) promises to be a highlight of the 2024 Vascular Annual Meeting (June 19–22). Funded by a grant from the Council of Medical Specialty Societies (CMSS) awarded to the SVS, the…
SVS launches registration for 3rd annual CPVI Skills Course
The Society for Vascular Surgery (SVS) has officially launched registration for the annual Complex Peripheral Vascular Initiatives (CPVI) Skills Course. The first course launched in 2022 after being put on hold in 2020 and 2021 due to the COVID-19 pandemic.…
‘The forgotten stepchild of vascular surgery’: The quest to push forward basic science research in venous disease
The 2024 Venous Symposium (May 8–11) in New York City was highlighted by keynote speaker Peter Pappas, MD, regional medical director and program director of the venous and lymphatic medicine fellowship at the Center for Vein Restoration in Morristown and…
First post-FDA approval implant of Duo venous stent system announced
Royal Philips today announced the first implant of the Duo venous stent system, indicated to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket approval (PMA) from the Food and Drug Association (FDA). On June…
AVS receives IDE approval from FDA for pivotal intravascular lithotripsy study
Amplitude Vascular Systems (AVS) announced today that it has received an investigational device exemption (IDE) from the Food and Drug Administration (FDA) to begin its pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy. The POWER-PAD-II clinical study will evaluate the…
VAM 2024: Changes to carotid stenting landscape in United States set to be discussed
Sean P. Lyden, MD, chairman of the Department of Vascular Surgery at Cleveland Clinic’s Heart, Vascular and Thoracic Institute in Cleveland, Ohio, will discuss the national coverage determination (NCD) changes passed by the Centers for Medicare & Medicaid Services (CMS)…
The top 10 most popular Vascular Specialist stories of May 2024
In April, the most read stories from Vascular Specialist include new data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial presented at the Leipzig Interventional Course (LINC) 2024 (28–31 May, Leipzig, Germany); recently released randomised data show cyanoacrylate glue…